drugset / Trial / NCT03362216
Clinical Efficacy and Safety of Compound Methyl Salicylate Liniment
RandomizedParallel-groupDouble-blindTreatment
Summary
This clinical trial program was established according to the ethical principles of the Helsinki declaration and the GCP guiding principle, and a randomized grouping method was used to evaluate the efficacy and safety of Compound Methyl Salicylate Liniment in the treatment of acute and chronic soft tissue pain with a positive control drug, named Diclofenac Sodium Liniment.
Timeline
- Start
- 2009-04-07
- Primary completion
- 2009-05-22
- Completion
- 2009-06-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Diclofenac | Other / unclassified | — | Topical |
| Subject | Methyl Salicylate | Small molecule | — | Topical |
Indications
No indication recorded.